Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain

Zhoumou Chen, Timothy M. Doyle, Livio Luongo, Tally M. Largent‐Milnes, Luigino Antonio Giancotti, Grant R. Kolar, Silvia Squillace, Serena Boccella, John K. Walker, Alexander L. Pendleton,

Proceedings of the National Academy of Sciences · 2019 · 137 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

Significance Understanding the cellular and molecular pathways of neuropathic pain is fundamental to discovering classes of non-opioid analgesics. Emerging evidence implicates altered sphingolipid metabolism and elevated levels of sphingosine-1-phosphate (S1P) in the spinal cord in the persistence of neuropathic pain, but its neuropharmacology and pathways engaged are poorly understood. Using a multidisciplinary approach, we provide evidence that S1P drives neuropathic pain by selectively activating the S1P receptor subtype 1 (S1PR1) in astrocytes. Inhibiting S1PR1 attenuated and reversed neuropathic pain by engaging the potent anti-inflammatory cytokine, interleukin 10. Our findings represent a paradigm shift in the understanding of S1PR1 signaling that has implications on the future development of S1PR1 antagonists as a promising class of nonnarcotic analgesics.

References

35